Companies: 10,795·Total market cap: $144.5T
OptimizeRx Corporation

OptimizeRx Corporation

OPRXNASDAQHealthcare● Active
$5.05
$-0.06(-1.17%)
Market Cap$94763629
P/E Ratio
52W High$22.25
52W Low$4.57
Overview

OptimizeRx Corporation (OPRX) Insider Trading

Form 4 buy vs sell counts, ratio, and sentiment — switch this quarter or last 12 months; chart and transactions below.

SEC EDGAR · FMP · OPRX · as of Jun 8, 2026

Activity summary

Buy transactions

0

P-Purchase only

Sell transactions

3

12 Months

Buy/Sell ratio

0.00

Buy/Sell (by trades)

Overall sentiment

BEARISH
↑ Buy 0%Active transactions only · RSU vesting excluded100% Sell ↓

OptimizeRx Corporation insiders have been primarily selling shares over the past 12 Months. Selling activity is often driven by pre-scheduled Rule 10b5-1 plans rather than negative sentiment toward the company.

Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · Buy = P-Purchase only · Sell = S-Sale only

As of Jun 8, 2026

OPRX insider buying and selling by quarter

OPRX insider selling · OPRX insider buying stocks · quarterly insider activity

Total insider buying (incl. awards)Total insider selling
602K301K0
2025 Q2
2025 Q3
2025 Q4
2026 Q1

Mobile shows last 4Q · Desktop shows full 8Q

Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · last 8 quarters

As of Jun 8, 2026

Active insiders

Most active in past 12 months · OPRX ceo insider trading

Showing all insiders · Click a card to filter the transactions table below

Aggregated from reportingName · top 5 by trade count (12M) · no extra API

Recent insider transactions

OPRX executive sell shares · OPRX board member insider trading · OPRX insider trading SEC filing

Showing 64 most recent · Common Stock · Form 4 only

Scroll horizontally to see all columns

Greco Theresa

Chief Commercial Officer

Other

Date

May 15

Shares

914

Price

$5.21

Value

$5K

View Form 4 on SEC.gov

Greco Theresa

Chief Commercial Officer

Other

Date

May 15

Shares

879

Price

$5.21

Value

$5K

View Form 4 on SEC.gov

Silvestro Stephen L

CEO

Other

Date

May 15

Shares

5,219

Price

$5.21

Value

$27K

View Form 4 on SEC.gov

Odence-Ford Marion

Chief Legal & Admin Officer

Option

Date

Feb 11

Shares

4,000

Price

Value

View Form 4 on SEC.gov

Odence-Ford Marion

Chief Legal & Admin Officer

Other

Date

Feb 11

Shares

1,386

Price

$9.23

Value

$13K

View Form 4 on SEC.gov

Greco Theresa

Chief Commercial Officer

Other

Date

Dec 23

Shares

1,420

Price

$12.74

Value

$18K

View Form 4 on SEC.gov

Silvestro Stephen L

CEO

Other

Date

Dec 23

Shares

3,361

Price

$12.74

Value

$43K

View Form 4 on SEC.gov

Odence-Ford Marion

Chief Legal & Admin Officer

Other

Date

Dec 23

Shares

4,051

Price

$12.74

Value

$52K

View Form 4 on SEC.gov

Besch Doug

Chief Product & Tech Officer

Other

Date

Dec 23

Shares

4,079

Price

$12.74

Value

$52K

View Form 4 on SEC.gov

Stelmakh Edward

Chief Finance & Strat Officer

Other

Date

Dec 23

Shares

3,658

Price

$12.74

Value

$47K

View Form 4 on SEC.gov

Stelmakh Edward

Chief Finance & Strat Officer

Option

Date

Dec 19

Shares

5,237

Price

Value

View Form 4 on SEC.gov

Stelmakh Edward

Chief Finance & Strat Officer

Sale

Date

Dec 19

Shares

1,388

Price

$13.51

Value

$19K

View Form 4 on SEC.gov

Silvestro Stephen L

CEO

Option

Date

Dec 19

Shares

6,546

Price

Value

View Form 4 on SEC.gov

Silvestro Stephen L

CEO

Other

Date

Dec 19

Shares

1,594

Price

$13.51

Value

$22K

View Form 4 on SEC.gov

Odence-Ford Marion

Chief Legal & Admin Officer

Option

Date

Dec 19

Shares

3,928

Price

Value

View Form 4 on SEC.gov

Odence-Ford Marion

Chief Legal & Admin Officer

Other

Date

Dec 19

Shares

1,153

Price

$13.51

Value

$16K

View Form 4 on SEC.gov

Merrell Brendan W.

CHIEF OPERATING OFFICER

Other

Date

Dec 19

Shares

289

Price

$13.51

Value

$4K

View Form 4 on SEC.gov

D'Silva Andrew J.

Chief Business Officer

Other

Date

Dec 19

Shares

703

Price

$13.51

Value

$9K

View Form 4 on SEC.gov

Besch Doug

Chief Product & Tech Officer

Option

Date

Dec 19

Shares

1,964

Price

Value

View Form 4 on SEC.gov

Besch Doug

Chief Product & Tech Officer

Other

Date

Dec 19

Shares

581

Price

$13.51

Value

$8K

View Form 4 on SEC.gov

Merrell Brendan W.

CHIEF OPERATING OFFICER

Other

Date

Dec 11

Shares

712

Price

$14.03

Value

$10K

View Form 4 on SEC.gov

D'Silva Andrew J.

Chief Business Officer

Other

Date

Dec 11

Shares

868

Price

$14.03

Value

$12K

View Form 4 on SEC.gov

Merrell Brendan W.

CHIEF OPERATING OFFICER

Award

Date

Aug 21

Shares

10,417

Price

Value

View Form 4 on SEC.gov

Merrell Brendan W.

CHIEF OPERATING OFFICER

Other

Date

Oct 3

Shares

483

Price

$18.75

Value

$9K

View Form 4 on SEC.gov

D'Silva Andrew J.

Chief Business Officer

Other

Date

Oct 1

Shares

414

Price

$18.98

Value

$8K

View Form 4 on SEC.gov

⚡ = value ≥ $1M · Award/Option price shows — · formType=4 · securityName=Common Stock · url → sec.gov/Archives/edgar

1 / 3

Source: SEC EDGAR · Form 4 filings · ⚡ = value ≥ $1M · Award/Option price shows —

About OPRX insider trading

OPRX insider trades

OptimizeRx Corporation (OPRX) insider trading data is sourced from SEC Form 4 filings submitted by corporate insiders, including Odence-Ford Marion (Chief Legal & Admin Officer), Silvestro Stephen L (CEO), Besch Doug (Chief Product & Tech Officer). Over the past 12 months, 5 insiders have filed transactions with the SEC. OPRX insiders have been primarily selling, which may reflect pre-scheduled Rule 10b5-1 plan executions.

For OptimizeRx Corporation's institutional ownership breakdown and insider ownership percentage, see the Ownership tab → Ownership tab →

Buy/Sell signal logic
acquisitionOrDisposition field:
A = Acquisition (buy) · D = Disposition (sell)
RSU vesting (M-Exempt) excluded from sentiment
Form 4SEC filing required within 2 business days of any insider transaction
10b5-1Pre-scheduled trading plan that allows insiders to sell on autopilot
Open MktDirect purchase or sale on the open market (excludes awards, options)

Frequently asked questions

OPRX insider trading · 5 questions

The insiders of OptimizeRx Corporation (OPRX) include executives and directors such as Odence-Ford Marion (Chief Legal & Admin Officer), Silvestro Stephen L (CEO), Besch Doug (Chief Product & Tech Officer), among others. Over the past 12 months, 5 insiders have filed Form 4 transactions with the SEC. Insider transactions are required to be reported within 2 business days of the trade date.

OPRX board member insider tradingwho are OPRX insidersOPRX insider rosterOptimizeRx Corporation executives insider activity

Source: FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · acquisitionOrDisposition A=Buy, D=Sell · RSU vesting (M-Exempt) excluded from sentiment bar · As of Jun 8, 2026